Long-term outcomes of HIV-infected children in Thailand: The Thailand pediatric HIV observational database

International Journal of Infectious Diseases

Volumn 22, Issue , 2014, Pages 19-24

  Phongsamart, Wanatpreeya ^a   Hansudewechakul, Rawiwan ^b   Bunupuradah, Torsak ^c   Klinbuayaem, Virat ^d   Teeraananchai, Sirinya ^c   Prasithsirikul, Wisit ^e   Kerr, Stephen J ^c,f   Akarathum, Noppadon ^d   Denjunta, Sukanda ^b   Ananworanich, Jintanat ^c,f,g   Chokephaibulkit, Kulkanya ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

^b Chiangrai Prachanukroh Hospital   (Thailand)

^c THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^d Sanpatong Hospital   (Thailand)

^e Bamrasnaradura Infectious Disease Institute   (Thailand)

^f UNIVERSITY OF NEW SOUTH WALES   (Australia)

^g CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Antiretroviral therapy; HIV; Long term outcome; Mortality

Indexed keywords

ANTIRETROVIRUS AGENT; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; VIRUS RNA;

ARTICLE; CD4 LYMPHOCYTE PERCENTAGE; CHILD; CHILDHOOD DISEASE; DATA BASE; DEATH; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PRESCHOOL CHILD; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCHOOL CHILD; SEX DIFFERENCE; THAILAND; TREATMENT DURATION; TREATMENT OUTCOME; WORLD HEALTH ORGANIZATION; ADOLESCENT; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; COHORT ANALYSIS; DRUG EFFECTS; FACTUAL DATABASE; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; MORTALITY; PATHOLOGY; PHYSIOLOGY; SURVIVAL; VIROLOGY; VIRUS LOAD;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; SURVIVAL ANALYSIS; THAILAND; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84896535784     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2013.12.011     Document Type: Article

References (14)

1. Patel K., Hernan M.A., Williams P.L., Seeger J.D., McIntosh K., Van Dyke R.B., et al. Long-term effectiveness of highly active antiretroviral therapy on the survival of children and adolescents with HIV infection: a 10-year follow-up study. Clin Infect Dis 2008, 46:507-515.
2. Brady M.T., Oleske J.M., Williams P.L., Elgie C., Mofenson L.M., Dankner W.M., et al. Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era. J Acquir Immune Defic Syndr 2010, 53:86-94.
3. Edmonds A., Yotebieng M., Lusiama J., Matumona Y., Kitetele F., Napravnik S., et al. The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med 2011, 8:e1001044.
4. Sauvageot D., Schaefer M., Olson D., Pujades-Rodriguez M., O'Brien D.P. Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age. Pediatrics 2010, 125:e1039-e1047.
5. Judd A., Doerholt K., Tookey P.A., Sharland M., Riordan A., Menson E., et al. Morbidity, mortality, and response to treatment by children in the United Kingdom and Ireland with perinatally acquired HIV infection during 1996-2006: planning for teenage and adult care. Clin Infect Dis 2007, 45:918-924.
6. Hansudewechakul R., Sirisanthana V., Kurniati N., Puthanakit T., Lumbiganon P., Saphonn V., et al. Antiretroviral therapy outcomes of HIV-infected children in the TREAT Asia Pediatric HIV Observational Database. J Acquir Immune Defic Syndr 2010, 55:503-509.
7. Lumbiganon P., Kariminia A., Aurpibul L., Hansudewechakul R., Puthanakit T., Kurniati N., et al. Survival of HIV-infected children: a cohort study from the Asia-Pacific region. J Acquir Immune Defic Syndr 2011, 56:365-371.
8. Isaakidis P., Raguenaud M.E., Te V., Tray C.S., Akao K., Kumar V., et al. High survival and treatment success sustained after two and three years of first-line ART for children in Cambodia. J Int AIDS Soc 2010, 13:11.
9. Global HIV/AIDS response: epidemic update and health sector progress towards universal access, progress report 2011. WHO, UNICEF, UNAIDS; 2011. Available at: (accessed September 4, 2012). http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2011/20111130_UA_Report_en.pdf.
10. Kariminia A., Chokephaibulkit K., Pang J., Lumbiganon P., Hansudewechakul R., Amin J., et al. Cohort profile: the TREAT Asia Pediatric HIV Observational Database. Int J Epidemiol 2011, 40:15-24.
11. Collins I.J., Jourdain G., Hansudewechakul R., Kanjanavanit S., Hongsiriwon S., Ngampiyasakul C., et al. Long-term survival of HIV-infected children receiving antiretroviral therapy in Thailand: a 5-year observational cohort study. Clin Infect Dis 2010, 51:1449-1457.
12. Leroy V., Malateste K., Rabie H., Lumbiganon P., Ayaya S., Dicko F., et al. Outcomes of antiretroviral therapy in children in Asia and Africa: a comparative analysis of the IeDEA pediatric multiregional collaboration. J Acquir Immune Defic Syndr 2013, 62:208-219.
13. Raguenaud M.E., Isaakidis P., Zachariah R., Te V., Soeung S., Akao K., et al. Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatr 2009, 9:54.
14. Ananworanich J., Prasitsuebsai W., Kosalaraksa P., Kanjanavanit S., Ngampiyaskul C., Wongsawat J., et al. Outcomes of third-line antiretroviral therapy containing darunavir, etravirine or raltegravir in Thai children with HIV infection. Poster session presented at: 4th International Workshop on HIV Pediatrics; 2012 July 20-24, XIX International AIDS Conference, July 22-27; Washington D.C., US 2012.